Low immunoglobulin G concentrations are not associated with an increased risk of peritoneal dialysis-related peritonitis.

IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY Clinical nephrology Pub Date : 2023-04-01 DOI:10.5414/CN110966
Geertje K M Biebuyck, Lily Jakulj, Aegida Neradova, Raymond T Krediet
{"title":"Low immunoglobulin G concentrations are not associated with an increased risk of peritoneal dialysis-related peritonitis.","authors":"Geertje K M Biebuyck,&nbsp;Lily Jakulj,&nbsp;Aegida Neradova,&nbsp;Raymond T Krediet","doi":"10.5414/CN110966","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Peritonitis is a common and severe complication of peritoneal dialysis (PD) and is associated with high morbidity and sometimes also with mortality. Identification of risk factors, as well as protective mechanisms for peritonitis, is important to reduce peritonitis-induced morbidity. According to the current literature, IgG concentrations might be associated with peritonitis in PD-treated patients. In this study, we aimed to investigate possible associations between dialysate or serum IgG concentration and peritonitis risk in a longitudinal cohort of PD-treated patients.</p><p><strong>Materials and methods: </strong>We analyzed prospectively collected data obtained during the first standard peritoneal permeability analysis (SPA), performed in incident PD patients, aged > 18 years who started PD treatment in our tertiary-care university hospital from January 1, 1994 until December 31, 2008. Patients were divided in groups according to dialysate or serum IgG concentrations and according to peritonitis incidence. A possible association between low dialysate or serum IgG concentrations and time to the first peritonitis episode was investigated using cox proportional hazard models.</p><p><strong>Results: </strong>120 patients were included in our analyses with a median follow-up time of 36 (16 - 92) months. No significant association between dialysate, nor serum IgG and time to peritonitis was found (HR 0.27 (95% CI 0.65 - 1.62), p = 0.911 and HR 0.87 (95% CI 0.70 - 1.68), p = 0.708, respectively). Moreover, IgG concentrations were not associated with peritonitis incidence, nor with the recurrence of peritonitis. Finally, we found no significant difference in dialysate or serum IgG concentrations between patients who remained peritonitis-free (58.0 ± 35.6 mg/L in dialysate, 11.1 ± 4.4 g/L in serum), and those who experienced a peritonitis episode during follow-up (59.5 ± 41.9 mg/L in dialysate, 10.3 ± 4.3 g/L in serum), respectively.</p><p><strong>Conclusion: </strong>Dialysate or serum IgG are not major determinants of local peritoneal defense against peritonitis.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":"99 4","pages":"180-186"},"PeriodicalIF":1.1000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5414/CN110966","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Peritonitis is a common and severe complication of peritoneal dialysis (PD) and is associated with high morbidity and sometimes also with mortality. Identification of risk factors, as well as protective mechanisms for peritonitis, is important to reduce peritonitis-induced morbidity. According to the current literature, IgG concentrations might be associated with peritonitis in PD-treated patients. In this study, we aimed to investigate possible associations between dialysate or serum IgG concentration and peritonitis risk in a longitudinal cohort of PD-treated patients.

Materials and methods: We analyzed prospectively collected data obtained during the first standard peritoneal permeability analysis (SPA), performed in incident PD patients, aged > 18 years who started PD treatment in our tertiary-care university hospital from January 1, 1994 until December 31, 2008. Patients were divided in groups according to dialysate or serum IgG concentrations and according to peritonitis incidence. A possible association between low dialysate or serum IgG concentrations and time to the first peritonitis episode was investigated using cox proportional hazard models.

Results: 120 patients were included in our analyses with a median follow-up time of 36 (16 - 92) months. No significant association between dialysate, nor serum IgG and time to peritonitis was found (HR 0.27 (95% CI 0.65 - 1.62), p = 0.911 and HR 0.87 (95% CI 0.70 - 1.68), p = 0.708, respectively). Moreover, IgG concentrations were not associated with peritonitis incidence, nor with the recurrence of peritonitis. Finally, we found no significant difference in dialysate or serum IgG concentrations between patients who remained peritonitis-free (58.0 ± 35.6 mg/L in dialysate, 11.1 ± 4.4 g/L in serum), and those who experienced a peritonitis episode during follow-up (59.5 ± 41.9 mg/L in dialysate, 10.3 ± 4.3 g/L in serum), respectively.

Conclusion: Dialysate or serum IgG are not major determinants of local peritoneal defense against peritonitis.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
低免疫球蛋白G浓度与腹膜透析相关性腹膜炎风险增加无关。
背景:腹膜炎是腹膜透析(PD)常见且严重的并发症,其发病率高,有时也与死亡率相关。识别危险因素,以及腹膜炎的保护机制,对于减少腹膜炎引起的发病率是重要的。根据目前的文献,IgG浓度可能与pd治疗患者的腹膜炎有关。在这项研究中,我们旨在调查透析液或血清IgG浓度与pd治疗患者腹膜炎风险之间的可能关联。材料和方法:我们对1994年1月1日至2008年12月31日在我院三级医院开始PD治疗的年龄> 18岁的PD患者进行第一次标准腹膜通透性分析(SPA)期间收集的前瞻性数据进行分析。根据透析液或血清IgG浓度及腹膜炎发生率进行分组。采用cox比例风险模型研究低透析液或血清IgG浓度与首次腹膜炎发作时间之间的可能关联。结果:120例患者纳入我们的分析,中位随访时间为36(16 - 92)个月。透析液、血清IgG与腹膜炎发生时间无显著相关性(HR 0.27 (95% CI 0.65 ~ 1.62), p = 0.911; HR 0.87 (95% CI 0.70 ~ 1.68), p = 0.708)。此外,IgG浓度与腹膜炎的发病率无关,也与腹膜炎的复发无关。最后,我们发现没有腹膜炎的患者(透析液58.0±35.6 mg/L,血清11.1±4.4 g/L)和随访期间发生腹膜炎的患者(透析液59.5±41.9 mg/L,血清10.3±4.3 g/L)的透析液或血清IgG浓度无显著差异。结论:透析液或血清IgG不是局部腹膜防御腹膜炎的主要决定因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical nephrology
Clinical nephrology 医学-泌尿学与肾脏学
CiteScore
2.10
自引率
9.10%
发文量
138
审稿时长
4-8 weeks
期刊介绍: Clinical Nephrology appears monthly and publishes manuscripts containing original material with emphasis on the following topics: prophylaxis, pathophysiology, immunology, diagnosis, therapy, experimental approaches and dialysis and transplantation.
期刊最新文献
Immunosuppressant-resistant nephrotic syndrome and primary amenorrhea: A case report of adult Frasier syndrome and literature review. The role of POCUS in sepsis-associated AKI in children. The efficacy and safety of low-dose roxadustat in combination with recombinant human erythropoietin for treating hemodialysis patients with moderate anemia: A retrospective cohort study. Analysis of the status and associated factors of stigma in patients undergoing maintenance hemodialysis. Human albumin infusion and risk of acute kidney injury in adults with nephrotic syndrome due to minimal change disease: A single-center retrospective study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1